Table 1.

Baseline characteristics of the experimental dataset

Characteristics	No. of participants (n = 2930)
Demographics
Age, (mean ± sdv.) [min-max]	62.27 ± 12.11 [28–91]
Gender, Male/Female	2079/851
Physical examination, (mean ± sdv.) [min-max]
Systolic BP, mm Hg	132.10 ± 17.64 [11–240]
Diastolic BP, mm Hg	77.59 ± 10.17 [35–120]
Height, cm	167.01 ± 8.15 [56–188]
Weight, kg	71.81 ± 12.42 [32–200]
Ejection Fraction, (mean ± sdv.) [min-max]	59.51 ± 7.82 [17–78]
Comorbid conditions (%)
Diabetes	803 (27.4%)
Hypertension	1981 (67.6%)
Heart Failure	165 (5.6%)
arteriosclerosis	2267 (77.4%)
History of current or previous smoking	1113 (38.0%)
Laboratory data, (mean ± sdv.) [min-max]
Creatinine, umol/L	78.72 ± 38.18 [29.5–739.4]
Creatinine kinase, umol/L	86.11 ± 112.02 [6.2–4651.1]
Alanine aminotransferase, umol/L	26.02 ± 27.66 [1.7–593]
Aspartate aminotransferase, umol/L	21.70 ± 19.53 [5.8–589.4]
Troponin T, ng/ml	0.029 ± 0.084 [0.002–0.886]
Glucose, umol/L	6.16 ± 2.26 [2.69–28.62]
Disease/Treatment history (%)
Post-PCI (patient who has taken PCI surgery in the past and was admitted into the hospital at this time)	816 (27.8%)
Post-CABG (patient who has taken CABG surgery in the past and was admitted into the hospital at this time)	46 (1.6%)
Length of Stay, (mean ± sdv.) [min-max]	9.12 ± 7.05 [1–54]
MACE (%)	752 (22.4%)